If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

"The development of JRT emphasizes that we can use psychedelics like LSD as starting points to make better medicines," Olson adds. The research follows other recent efforts to show the medical ...

But even before the medical reports were in, his background became known. He was a Harvard undergraduate in 1952-57, too early to hear Psychologist Timothy Leary expounding the beauties of LSD and ...

Get Instant Summarized Text (Gist) A new drug, JRT, derived from LSD, shows promise for treating schizophrenia by promoting neuroplasticity without causing hallucinations. By altering two atoms in ...

Could a subtle tweak to lysergic acid diethylamide (LSD) unlock its therapeutic potential, without the trip? In a study published in Proceedings of the National Academy of Sciences, researchers at the ...

These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and depression. Some claim the practice gives them access to joy, creativity and ...

LSD “hits you where you are most blocked ... aftermath — but charges were dropped after Ingrasci surrendered his medical license. But perhaps psychiatrist Sidney Cohen came closest to ...

The federal government classified LSD as a Schedule I drug, meaning the substance is not recognized as serving an accepted medical use and is labeled as having a high potential for abuse.

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...